Multicenter retrospective study to evaluate the impact of trabectedin plus pegylated liposomal doxorubicin on the subsequent treatment in women with recurrent, platinum-sensitive ovarian cancer-Reference-Cited by-同舟云学术

Multicenter retrospective study to evaluate the impact of trabectedin plus pegylated liposomal doxorubicin on the subsequent treatment in women with recurrent, platinum-sensitive ovarian cancer

Published:2019-07 Issue:6 Volume:30 Page:628-635
ISSN:0959-4973
Container-title:Anti-Cancer Drugs
language:en
Short-container-title:

Author:

Romero Ignacio,Mallol Pedro,Santaballa Ana,Del Campo Jose M.,Mori Marta,González-Santiago Santiago,Casado Antonio,Vicente David,Ortega Eugenia,Herrero Ana,Guerra Eva,Barretina-Ginesta Pilar,Rubio María J.,Martínez Alejandro,Bover Isabel,Vidal Laura,Arcusa Ángels,Martín Lola,García Yolanda,González-Martín Antonio

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology (medical),Pharmacology,Oncology

Reference40 articles.

1. Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.;Ledermann;Ann Oncol,2013

2. The detection, treatment, and biology of epithelial ovarian cancer;Gubbels;J Ovarian Res,2010

3. Epidemiology of ovarian cancer: a review;Reid;Cancer Biol Med,2017

4. Pathology of ovarian cancers in BRCA1 and BRCA2 carriers;Lakhani;Clin Cancer Res,2004

5. The current treatment of recurrent ovarian cancer;Herzog;Curr Oncol Rep,2006

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DNA Damage Response Alterations in Ovarian Cancer: From Molecular Mechanisms to Therapeutic Opportunities;Cancers;2023-01-10

2. Trabectedin induces ferroptosis via regulation of HIF-1α/IRP1/TFR1 and Keap1/Nrf2/GPX4 axis in non-small cell lung cancer cells;Chemico-Biological Interactions;2023-01

3. Effects of Laparoscopic Hyperthermic Perfusion Therapy Combined with Adjuvant Treatment of Compound Yew Capsule on Ovarian Blood Flow Parameters and Immune Function in Patients with Ovarian Cancer;Evidence-Based Complementary and Alternative Medicine;2022-07-13

4. Trabectedin in Cancers: Mechanisms and Clinical Applications;Current Pharmaceutical Design;2022-07

5. Real-world experience with trabectedin for the treatment of recurrent ovarian cancer;Expert Review of Anticancer Therapy;2021-06-21